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analysis reveals the intricacies of human imprinting
and suggests a germline methylation-independent
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Differential methylation between the two alleles of a gene has been observed in imprinted regions, where the methylation
of one allele occurs on a parent-of-origin basis, the inactive X-chromosome in females, and at those loci whose methylation
is driven by genetic variants. We have extensively characterized imprinted methylation in a substantial range of normal
human tissues, reciprocal genome-wide uniparental disomies, and hydatidiform moles, using a combination of whole-
genome bisulfite sequencing and high-density methylation microarrays. This approach allowed us to define methylation
profiles at known imprinted domains at base-pair resolution, as well as to identify 21 novel loci harboring parent-of-origin
methylation, 15 of which are restricted to the placenta. We observe that the extent of imprinted differentially methylated
regions (DMRs) is extremely similar between tissues, with the exception of the placenta. This extra-embryonic tissue often
adopts a different methylation profile compared to somatic tissues. Further, we profiled all imprinted DMRs in sperm and
embryonic stem cells derived from parthenogenetically activated oocytes, individual blastomeres, and blastocysts, in
order to identify primary DMRs and reveal the extent of reprogramming during preimplantation development. In-
triguingly, we find that in contrast to ubiquitous imprints, the majority of placenta-specific imprinted DMRs are
unmethylated in sperm and all human embryonic stem cells. Therefore, placental-specific imprinting provides evidence
for an inheritable epigenetic state that is independent of DNA methylation and the existence of a novel imprinting
mechanism at these loci.
[Supplemental material is available for this article.]
Genomic imprinting is a form of epigenetic regulation that results
in the expression of either the maternally or paternally inherited
allele of a subset of genes (Ramowitz and Bartolomei 2011). This
imprinted expression of transcripts is crucial for normal mamma-
lian development. In humans, loss-of-imprinting of specific loci
results in a number of diseases exemplified by the reciprocal growth
phenotypes of the Beckwith-Wiedemann and Silver-Russell syn-
dromes, and the behavioral disorders Angelman and Prader-Willi
syndromes (Kagami et al. 2008; Buiting 2010; Choufani et al. 2010;
Eggermann 2010; Kelsey 2010; Mackay and Temple 2010). In ad-
dition, aberrant imprinting also contributes to multigenic disorders
associated with various complex traits and cancer (Kong et al. 2009;
Monk 2010).
Imprinted loci contain differentially methylated regions
(DMRs) where cytosine methylation marks one of the parental
alleles, providing cis-acting regulatory elements that influence the
allelic expression of surrounding genes. Some DMRs acquire their
allelic methylation during gametogenesis, when the two parental
genomes are separated, resulting from the cooperation of the de
novo methyltransferase DNMT3A and its cofactor DNMT3L
(Bourc’his et al. 2001; Hata et al. 2002). These primary, or germline
imprinted DMRs are stably maintained throughout somatic de-
velopment, surviving the epigenetic reprogramming at the oocyte-
to-embryo transition (Smallwood et al. 2011; Smith et al. 2012). To
confirm that an imprinted DMR functions as an imprinting con-
trol region (ICR), disruption of the imprinted expression upon
genetic deletion of that DMR, either through experimental tar-
geting in mouse or that which occurs spontaneously in humans, is
required. A subset of DMRs, known as secondary DMRs, acquire
methylation during development and are regulated by nearby
germline DMRs in a hierarchical fashion (Coombes et al. 2003;
Lopes et al. 2003; Kagami et al. 2010).
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With the advent of large-scale, base-resolution methylation
technologies, it is now possible to discriminate allelic methylation
dictated by sequence variants from imprinted methylation. Yet our
knowledge of the total number of imprinted DMRs in humans, and
their developmental dynamics, remains incomplete, hampered by
genetic heterogeneity of human samples.
Here we present high-resolution mapping of human imprinted
methylation. We performed whole-genome-wide bisulfite sequenc-
ing (WGBS) on leukocyte-, brain-, liver-, and placenta-derived DNA
samples to identify partially methylated regions common to all
tissues consistent with imprinted DMRs. We subsequently con-
firmed the partial methylated states in tissues using high-density
methylation microarrays. The parental origin of methylation was
determined by comparing microarray data for DNA samples from
reciprocal genome-wide uniparental disomy (UPD) samples, in
which all chromosomes are inherited from one parent (Lapunzina
and Monk 2011), and androgenetic hydatidiform moles, which are
created by the fertilization of an oocyte lacking a nucleus by
a sperm that endoreduplicates. The use of uniparental disomies
and hydatidiform moles meant that our analyses were not sub-
jected to genotype influences, enabling us to characterize all
known imprinted DMRs at base-pair resolution and to identify 21
imprinted domains, which we show are absent in mice. Lastly, we
extended our analyses to determine the methylation profiles of all
imprinted DMRs in sperm, stem cells derived from parthenoge-
netically activated metaphase-2 oocyte blastocytes (phES) (Mai
et al. 2007; Harness et al. 2011), and stem cells (hES) generated
from both six-cell blastomeres and the inner cell mass of blasto-
cysts, delineating the extent of embryonic reprogramming that
occurs at these loci during human development.
Results
Characterization of parent-of-origin methylation profiles
in human tissues using high-resolution approaches
We combined whole-genome bisulfite sequencing with Illumina
Infinium HumanMethylation 450K BeadChip arrays to generate
methylation profiles. To validate this approach, we compared the
DNA methylation profiles generated by each method. Methylation
scores produced by the two methods are very similar when the
same DNA samples were assessed by both techniques (linear re-
gression WGBS vs. Infinium array: leukocytes R2 = 0.92; brain R2 =
0.91; placenta R2 = 0.92) (Supplemental Fig. S1). To determine the
similarity between normal biparental leukocytes and those from
reciprocal genome-wide UPDs, we compared the methylation
values obtained from the Infinium array. This revealed high cor-
relations between samples, indicating that the DNAs were similar,
differing only at imprinted loci (linear regression: leukocytes vs.
leukocytes R2 = 0.95–0.98; mean control leukocytes vs. mean
pUPD R2 = 0.98; mean control leukocytes vs. mUPD R2 = 0.98;
mUPD vs. mean pUPD R2 = 0.97; F-statistics P < 0.001).
Before we attempted to discover novel imprinted DMRs in the
human genome, we wished to determine the effectiveness of the
Infinium array to identify known imprinted DMRs. Loci were
identified which contained at least three Infinium probes with an
average minimal difference of 0.3 b-values (absolute methylation
difference >30%) between reciprocal genome-wide UPD leukocyte
samples, and with a prerequisite that the b-values for normal leu-
kocytes should be between these extremes. Using these criteria, we
identified 818 windows that could be merged into 145 regions
harboring 576 probes incorporating 30 known DMRs within 25
imprinted domains (Table 1; Fig. 1A) (Limma linear model P <
0.05), and presented an intermediate methylation profile in all
somatic tissues (Fig. 1B). The only imprinted DMRs not found
using this approach were the IG-DMR located between MEG3 and
DLK1 on chromosome 14, as this region does not have probes on
this array platform and IGF2-DMR0 only contains a single probe.
Identification of new DMRs within known imprinted domains
In addition to the known imprinted DMRs, the Infinium array
screen of reciprocal UPDs and tissues samples uncovered several
previously unidentified DMRs located within existing imprinted
domains. We discovered four maternally methylated CpG islands
located between the SNRPN and NDN genes on chromosome 15,
a region associated with the Angelman and Prader-Willi syndromes.
The methylation profiles at the SNRPN, NDN, and MAGEL2 pro-
moters are well-established (El-Maarri et al. 2001; Sharp et al. 2010).
However, little is known about the intervening ;1-Mb gene-poor
region, which is likely to have arisen from an ancient duplication
event, since these novel DMRs share 97.8% sequence identity with
additional CpG-rich regions in the interval. We confirm the ma-
ternal methylation at these four regions using bisulfite PCR and
sequencing, incorporating heterozygous SNPs in brain and leuko-
cyte DNA (Supplemental Fig. S2A). Further analysis of this region
revealed that the promoter region for MKRN3 and MIR4508 are also
differentially methylated.
Extending our analysis to imprinted domains on other auto-
somes, we identified an ;600-bp interval of maternal methylation
4 kb 39 from the ZNF597 gene (Fig. 1C). Although the promoter of
ZNF597 is a paternally methylated bidirectional silencer pre-
sumably responsible for regulating the imprinted expression of
both ZNF597 and NAA60 (previously known as NAT15), this region
is unlikely to be the ICR for the domain as its methylation is so-
matically acquired (Nakabayashi et al. 2011). In addition, WGBS
and Infinium array data sets revealed a maternally methylated DMR
within intron 2 of MEG8 within the chromosome 14 imprinted
domain (Supplemental Fig. S2B). Lastly, we identify two maternally
methylated regions. The first is an ;1-kb CpG island overlapping
the promoter of isoform 3 of the ZNF331 gene, and the second
coincides with exon 2 of DIRAS3 (Supplemental Fig. S2C).
Genome-wide methylation profiling identifies novel imprinted
domains
To determine if there are additional imprinted DMRs in the human
genome, we screened for regions of intermediate methylation
common to lymphocyte, brain, and liver WGBS data sets. Using
a sliding window approach that takes into account 25 consecutive
CpG sites and following removal of class 1 transposable elements
(LINEs, Alu/SINEs, and LTR elements) and satellite DNA, we iden-
tified 356 nonoverlapping, single-copy regions in pairwise com-
parisons of tissues, of which 63 loci were common to the all tissues
(0.25 < mean 6 1.5 SD < 0.75) (Fig. 2A; Supplemental Table S1).
A screen for three consecutive partially methylated probes in
leukocyte, brain, liver, kidney, and muscle Infinium data sets, with
a profile consistent with parent-of-origin methylation in the re-
ciprocal UPD leukocyte samples, identified 116 regions (Supple-
mental Table S1). By combining the 356 regions detected by WGBS
and the 116 loci identified by the Infinium array, we identified 64
regions in common, which included all known imprinted DMRs
and 17 CpG-rich sequences possessing a methylation profile con-
sistent with imprinting. Using standard bisulfite PCR, we assessed
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all regions and verified that six regions (PPIEL, WDR27, HTR5A,
WRB, NHP2L1, ERLIN2 loci) are maternally methylated. The DMR
we identify within intron 7 of ERLIN2 appears to be a retro-
insertion of the CXorf56 pseudogene (also known as LOC728024)
(Fig. 2B,C; Supplemental Fig. S3; Supplemental Table S1).
To confirm that parent-of-origin transcription occurs near
these novel imprinted DMRs, we performed allelic RT-PCR in
a panel of tissues with primers that discriminate major variant
transcripts within each region. This revealed that the DMRs asso-
ciated with WDR27, NHP2L1, and CXorf56 pseudogenes regulate
allelic expression in an isoform-specific fashion (Fig. 2B,C; Sup-
plemental Fig. S3; Supplemental Table S1). We detect monoallelic
expression of a short alternatively polyadenylated ERLIN2 tran-
script which independently substantiates the observation that the
generation of retrogenes, primarily from the X chromosome, is
a common mechanism for generating imprinted loci (Wood et al.
2008; Kanber et al. 2009). Unfortunately, due to the lack of in-
formative polymorphisms or expression in available heterozygous
tissues, we could not perform allelic expression analysis for PPIEL,
HTR5A, and WRB.
Histone methylation of H3K4 and DNA methylation
are enriched on opposing alleles at imprinted DMRs
GC-rich sequences often coincide with enrichment of H3K4me3,
which may act to protect them from de novo methylation
(Thomson et al. 2010). The H3K4 demethylase KDM1B (previously
known as AOF1) is required for appropriate establishment of ma-
ternal germline methylation for a subset of imprinted DMRs in
mouse, suggesting that the presence of H3K4 methylation is re-
fractory to DNA methylation deposition in the female germline
(Ciccone et al. 2009). By comparing publicly available data sets for
ChIP-seq for H3K4me3 and methylated DNA immunoprecipita-
tion (meDIP-seq) from blood and brain, we observe co-enrichment
of these opposing epigenetic marks at 89.5% of imprinted DMRs,
consistent with differential active and repressive chromatin states
on homologous chromosomes. For a limited number of infor-
mative regions, we were able to confirm H3K4me3 precipitation
on the unmethylated allele (Fig. 3C). In most cases, the methyla-
tion profile of maternally methylated DMRs is more closely related
to the opposing H3K4me3 profile rather than to the CpG density
that classically defines CpG islands (>200 bp, GC content >50%,
observed/expected ratio >0.6), with the exception of the GNAS-XL
DMR. This maternally methylated region was thought to be a sin-
gle regulatory unit; however, our WGBS and Infinium array data
clearly show that it is two separate DMRs, partitioned by an ;200-
bp interval of hypermethylation, with the centromeric GNAS-AS1
(previously known as NESP-AS) promoter showing coenrichment
for H3K4me3 and DNA methylation, while the GNAS-XL side lacks
this permissive histone modification (Fig. 3A).
Further interrogation of this data set identified two DMRs
associated with multiple promoters with a gradient effect across
the CpG-rich sequences. The GNAS/GNAS EX1A CpG island (CpG
island 320 in Fig. 3A) is unmethylated on one side, coinciding with
H3K4me3, whereas the other is differentially methylated with
abundant H3K4me3 and meDIP reads. This pattern was also ob-
served in the bidirectional HTR5A/HTR5A-AS1 promoter in brain
(Fig. 3B), a tissue where these transcripts are most abundant.
Tissue-specific dynamics of imprinted DMRs
The WGBS analysis in leukocytes, brain, and liver confirmed that
the extent of allelic methylation at the imprinted DMRs, as defined
by the size of the intermediately methylated interval, is highly
similar in these somatic tissues (Figs. 1, 4; Table 1). However, some
regions were drastically different in the placenta.
By comparing the placental WGBS profile with Infinium
b-values for placentae and hydatidiform moles, we observe that the
DMRs associated with the maternally methylated PEG10 and the
paternally methylated H19 are significantly larger in placenta than
in somatic tissues. Using standard bisulfite PCR and sequencing, we
confirm that the somatically unmethylated SGCE promoter, imme-
diately adjacent to the differentially methylated PEG10 promoter, is
methylated on the maternal allele in placenta, while the maternal
allele overlapping the H19 gene body is demethylated (Fig. 4B).
In addition to identifying extended DMRs in the placenta, we
also observe complex tissue-specific methylation between somatic
tissues and placenta. For example, the NNAT and GNAS-AS1 DMRs,
which are maternally methylated in somatic tissue, exhibit
hypermethylation in both placenta and hydatidiform mole. Sub-
sequent bisulfite PCR confirmed that these regions are fully
methylated in the placenta (Supplemental Fig. S4). Methylation
profiling at the MIR512-1 cluster (also known as C19MC)-ZNF331
locus on chromosome 19 has previously disclosed that the pro-
moter of the pri-miRNA for this miRNA cluster is maternally
methylated in placenta, but fully methylated in somatic tissues
(Noguer-Dance et al. 2010). We confirm that the MIR512-1 DMR is
unmethylated in hydatidiform moles compared to the partially
methylated profile in placenta, with placental WGBS revealing
that the DMR is ;5 kb in size, incorporating the promoter CpG
island (CpG island 86 in Fig. 4C). However, we notice that the CpG
island (CpG island 83 in Fig. 3C) associated with ZNF331 isoform-3
is hypermethylated on both parental alleles in placenta but is
a maternally methylated DMR in somatic tissues. These methyla-
tion states dictate complex allelic expression at this locus, with
restricted placental-specific paternal expression of the MIR512-1
pri-miRNA, which does not extend to the MIR371/2 cluster, and
reciprocal imprinting of ZNF331 (Fig. 4C; Supplemental Table S2).
Novel placental-specific DMRs associated with paternally
expressed transcripts
Based on the complex methylation profiles described above, we
next investigated if more unknown imprinted DMRs exist solely in
Figure 1. Identification of known imprinted DMRs on the Infinium array platform. (A) Circular karyotype showing the difference of methylation for three
consecutive probes for reciprocal UPD leukocyte samples. Red dots indicate a minimal difference of 0.3 in Infinium probe b-values (>30% absolute
methylation value) for regions with maternal methylation, and blue dots indicate the same for paternal methylation. Known DMRs are indicated. (B) Heat
map of the Infinium probes located within known imprinted DMRs in reciprocal genome-wide UPD samples and various somatic tissues. (C ) WGBS and
Infinium array methylation profiles of the ZNF597 locus with bisulfite PCR confirmation of the novel maternally methylated DMR and its position in relation
to the somatic paternally methylated promoter region. Vertical gray lines in the WGBS tracks represent the mean methylation value for individual CpG
dinucleotides calculated from multiple data sets, with the light gray lines representing the mean + standard deviation. Infinium methylation values for
normal tissues are represented by black dots, with values for the genome-wide UPDs (average pUPD in blue and mUPD in red) superimposed on the
leukocyte methylation track. The error bars associated with the Infinium array probes represent the standard deviation of multiple biological samples.
The PCR confirmation in placenta, kidney, and leukocyte-derived DNA was performed on heterozygous samples. Each circle represents a single CpG
dinucleotide on a DNA strand. (•) Methylated cytosine, (s) unmethylated cytosine. Each row corresponds to an individual cloned sequence.
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placental tissues, as highlighted by the MIR512-1 and GPR1-AS
DMRs (Noguer-Dance et al. 2010; Kobayashi et al. 2013).
We performed a screen for partially methylated regions pres-
ent solely in our placenta WGBS data set using our sliding window
approach (0.25 < mean of 25 CpG 6 2 SD < 0.75). This identified
722 windows, of which 520 mapped to CpG islands. These results
confirm that placental-derived DNA is significantly less methyl-
ated when compared to other tissues (Schroeder et al. 2013) and
that this genome-wide lower methylation is not restricted to re-
petitive elements as previously described (Ehrlich et al. 1982; Fuke
et al. 2004), but occurs across a large portion of the genome.
Of these partially methylated placenta domains identified by
WGBS, 44 regions were ;50% methylated in placenta, with ex-
treme methylation in hydatidiform moles using the Infinium array
(average b-value for three consecutive probes >0.8 indicative of
paternal methylation or <0.2 indicative of maternal methylation),
and showed no evidence of allelic methylation in somatic tissues.
Using standard bisulfite PCR, we assessed the allelic methylation
profile of all regions in placental DNA samples. This revealed that
the promoters of N4BP2L1, DCAF10, PDE4D, FAM196A, RGMA,
AGBL3, MCCC1, ZC3H12C, DNMT1, AIM1, ZNF396, FAM20A,
GLIS3, and LIN28B are methylated on the maternal allele (Fig. 4D;
Supplemental Fig. S5; Supplemental Table S2). In addition, we
identified a 2.8-kb region of intermediate methylation overlapping
an alternative promoter of the paternally expressed ZFAT gene in
the placental WGBS data set (Supplemental Fig. S5). Using allelic-
specific bisulfite PCR, we confirm that the methylation is confined
to the maternal chromosome at this locus. To determine if these
regions of maternal methylation influence transcription, allelic
RT-PCR experiments were carried out. Paternal expression of eight
of these genes was verified, with biallelic expression in somatic
tissues (Fig. 4D; Supplemental Fig. S5; Supplemental Table S2)
consistent with recent allelic expression screens in term placenta
(Yuen et al. 2011; Barbaux et al. 2012).
Mammalian conservation of novel imprinted domains
To determine if the previously unrecognized imprinted domains
are conserved throughout evolution, we assessed their allelic
methylation and expression in mice, using a reciprocal cross be-
tween mouse strains. Bisulfite PCR targeting of orthologous regions
failed to identify evidence of differential methylation in embryonic
day E9.5–14.5 embryos or extra-embryonic tissues. Subsequent al-
lelic RT-PCRs revealed that all murine transcripts orthologous to the
novel ubiquitous and placental-specific imprinted transcripts are
equally expressed from both parental alleles when detected (Sup-
plemental Figs. S6, S7). This suggests that these new imprinted do-
mains arose less than ;80 million years ago after the divergence of
mice and humans or that selection pressures over this period have
resulted in a loss of imprinted regulation of these genes in mice. It
has been previously reported that imprinting in the placenta dif-
fers between human and mouse, mainly due to the lack of im-
printing of genes which require repressive histone modifications
for allelic silencing in humans (Monk et al. 2006). Contrary to
previous reports, our results show that humans have evolved more
loci subject to this form of transcriptional regulation in placenta,
due to the evolutionary acquisition of loci with parent-of-origin
methylation. This is endorsed by the low discovery rate of novel
imprinted transcripts in RNA-seq screens of mouse placenta (Okae
et al. 2011).
Differential methylation at ubiquitously imprinted loci and
placental-specific domains may differ in their gametic origin
An essential step toward understanding the establishment of the
germline imprint signal is to determine if the parent-of-origin
methylation observed in somatic tissues is derived from the
germline. Determining the methylation profiles in human gam-
etes and during the early preimplantation stages of embryonic
development is technically and ethically challenging. To circum-
vent these difficulties, we have used a combination of mature
gametes and in vitro models to represent human gametes of both
sexes and preimplantation embryos. For analysis during gameto-
genesis in males, we used mature sperm. We compared publicly
available WGBS data sets from sperm and human embryonic stem
(hES) cells that represent the inner cell mass of the blastocysts
(Lister et al. 2009; Molaro et al. 2011) with our own Infinium array
profiles for sperm, parthenote-derived hES cell lines (phES), and
hES cell lines generated from both six-cell blastomeres (Val10B)
and the inner cell mass of blastocysts (SHEF cell lines). Despite the
phES cell lines having undergone reprogramming during blasto-
cyst development, they have previously been shown to retain
maternal hypermethylation at the limited imprinted loci assessed,
suggesting that they are ideal surrogates for assessing the methyl-
ation profiles of imprinted DMRs in mature oocytes (Mai et al.
2007; Harness et al. 2011).
A comparison of Infinium b-values between sperm and phES
cells for the human sequences orthologous to the mouse germline
DMRs (Kobayashi et al. 2012) revealed that 19/22 are conserved.
The novel ubiquitous DMRs we identify are also hypermethylated
in phES cells and unmethylated in sperm, suggesting that the
majority of imprinted DMRs, with the exception of IGF1R, are
primarily marked in the gametes (Fig. 5A; Supplemental Fig. S8). In
addition, we confirm that the IG-DMR within the chromosome 14
domain is >80%–90% methylated in the sperm WGBS data set, in
line with previous reports (Geuns et al. 2007). We were particularly
intrigued to observe that all placental-specific DMRs, with the
exception of ZFAT, GPR1-AS, and MIR512-1, do not inherit meth-
ylation from the gametes and are devoid of methylation in hES
cells (Fig. 5A). These data provide preliminary evidence to suggest
that, following gametogenesis, parental alleles at some loci retain
a nonequivalency that is not associated with DNA methylation.
Figure 2. Identification and characterization of allelic methylation and expression of novel imprinted loci. Circular karyotype showing the position of
common regions of intermediate methylation in the leukocyte, brain, and liver WGBS data sets, as identified using a 25 CpG sliding window approach
(0.25 < mean 6 1.5 SD < 0.75). Red ticks represent sites of intermediate methylation common to all tissues, whereas black ticks identify those present in
only one or two pairwise comparisons. The position of known imprinted DMRs are shown. (B) Identification of a novel maternally methylated DMR within
the WDR27 locus by WGBS and Infinium array analysis. Vertical gray lines in the WGBS tracks represent the mean methylation value for individual CpG
dinucleotides calculated from multiple data sets, with the light gray lines representing the mean + standard deviation. Infinium methylation values for
normal tissues are represented by black dots, with values for the genome-wide UPDs (average pUPD in blue and mUPD in red) superimposed on the
leukocyte methylation track. The DMR was confirmed using standard bisulfite PCR on heterozygous DNA samples and orchestrates paternal expression of
WDR27 isoform 2. The asterisk (*) in the sequence traces shows the position of the polymorphic base. (C ) Imprinting of ERLIN2 isoform 1 in leukocytes as
a consequence of the retrotransposition of the X chromosome-derived CXorf56 pseudogene into the locus.
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Figure 3. H3K4me3 chromatin profile and DNA methylation at imprinted loci. (A) Map of the human GNAS locus on chromosome 20 with the H3K4me3
and meDIP signatures in brain and leukocytes at the DMRs identified in the WGBS and Infinium array analysis. Infinium methylation values for normal
leukocytes (black dots), with values for the genome-wide pUPD (blue) and mUPD (red) superimposed on the leukocyte WGBS track. Similarly, Infinium
methylation values for two normal brain samples are shown as black and gray dots. The light and dark gray peaks in the meDIP and ChIP-seq panels represent
two independent biological replicates compared to input (black peaks). The bars under the CpG islands, as identified in the UCSC Genome Browser, show the
location of the bisulfite PCR amplicons. (B) The gradient DMR identified at the HTR5A promoter. The samples used for the WGBS, Infinium array, and ChIP are
the same as in A. The independent methylation pattern on either side of the bidirectional promoter interval was confirmed using standard bisulfite PCR and
sequencing. (C ) Allelic ChIP for H3K4me3 reveals predominant enrichment of this histone modification on the unmethylated allele of the H19 ICR, SNURF
ICR, NNAT, and MCTS2P DMRs. The asterisk (*) in the sequence traces shows the position of the polymorphic base.
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Therefore, in the female germline, as represented by the phES cells,
a subset of imprinted loci retain their identity in the absence of
methylation, suggesting that additional epigenetic mechanisms
mark these regions for maternal methylation during trophoblast
differentiation (Fig. 5A).
For the majority of DMRs for which allelic methylation was
observed in the somatic tissues (80%), the genomic interval
showing methylation differences between sperm and phES cells is
larger than the allelic DMRs in hES cells and somatic tissues (Fig.
5B,C). In the case of maternally methylated DMRs, we observe that
these regions are flanked by fully methylated intervals in both
gametes, and that these DMRs are observed as regions devoid
of methylation in the sperm genome. Interrogation of ChIP-seq
data sets for nucleosomes containing the histone modifications
revealed that the majority of unmethylated DMR regions in sperm
are enriched for H3K4me3 containing nucleosome fractions. Our
analysis indicates that the size of the unmethylated region in
sperm is therefore associated with nucleosome occupancy, rather
than protamines. Notably, the maternally methylated germline
DMR overlapping the NNAT promoter is ;4 kb, as defined by full
methylation in phES cell and the H3K4me3 enriched DNA
unmethylated region in sperm. This region contracts to an ;1.5-kb
region of maternal methylation after preimplantation repro-
gramming as represented by blastocyst-derived hES cells and so-
matic tissue profiles (Fig. 5C; Supplemental Fig. S9A showing the
contraction at the NAP1L5 locus). Such resizings are also observed
in mouse (Tomizawa et al. 2011), suggesting that imprinted DMRs
are not totally protected from genome-wide demethylation during
the oocyte to embryo transition. We speculate that the larger
regions of differential methylation dictated by the gametes, in
combination with protective factors, ensure that they survive
reprogramming.
In addition, we also observe other subtle differences in
germline-derived methylation profiles. For example, the two sides
of the GNAS-XL DMR that we show to have independent H3K4
methylation profiles from each other behave differently in the
germline, with the GNAS-AS1 side being a somatic DMR only, but
the GNAS-XL side being methylated in phES cells and hypo-
methylated in sperm (Supplemental Fig. S4). Lastly, we identified
a dynamic relocalization of methylation at the FAM50B DMR
during preimplantation development. The 1.2-kb promoter of this
imprinted retrogene is methylated on the maternal allele in so-
matic tissues but is completely unmethylated in phES cells and hES
cells derived from six-cell embryos, and has been shown to be
unmethylated in sperm (Nakabayashi et al. 2011). However, we do
find that allelic methylation is conferred during preimplantation
development, at a point between the six-cell stage and blastocyst
development. In fact, the ;1-kb regions flanking the promoter
(labeled 1 and 3 in Supplemental Fig. S9B) show strongly opposing
methylation profiles, with the sperm being unmethylated and
phES cells methylated, which then become fully methylated on
both alleles immediately after fertilization, leaving allelic methyl-
ation over the promoter itself.
Discussion
Differentially methylated regions between the parental alleles are
essential for genomic imprinting and development. In this study,
we have performed a comprehensive survey of methylation in
various human tissues, uncovering all known imprinted DMRs as
well as 21 novel loci, which we demonstrate wherever possible
regulate imprinted transcription. Our present work demonstrates
that the human genome contains a significantly larger number of
regions of parent-of-origin methylation than previously thought.
The identification of imprinted domains has traditionally been
performed in mouse by utilizing gynogenetic and androgenetic
embryos, mice harboring regions of uniparental disomies, or highly
polymorphic inbred strains (Cooper and Constância 2010). These
embryos have been subjected to expression-based screens, in-
cluding RNA-seq (Gregg et al. 2010; Okae et al. 2011), and genome-
wide methylation techniques (Hayashizaki et al. 1994; Kelsey et al.
1999; Hiura et al. 2010). By relying on the confirmation of the
evolutionarily conserved expression of the human orthologs,
imprinted genes specific to higher primates and humans would
have been missed. We have utilized high-throughput bisulfite
analysis from in vitro models of gametes and early embryos, and
somatic and placental DNA, to characterize the developmental dy-
namics of imprinted methylation coupled with allelic expression
analysis of nearby transcripts. This analysis reveals that 30 regions of
parentally inherited differential methylation are observed in
humans but not mice. Conversely, we also show that the DMRs as-
sociated with Cdkn1c, Rasgrf1, the Igf2r promoter, Impact, Slc38a4,
and Zrsr1 (previously known as U2af1-rs1) imprinted transcripts in
mouse do not exhibit allelic methylation in humans (Xie et al. 2012).
Recently, a novel mechanism has been described in which
differences in germline methylation can give rise to tissue-specific
DMRs in mouse (Proudhon et al. 2012). The Cdh15 DMR inherits
methylation from the oocyte and maintains this parental allelic
methylation during in utero development and in adults, with the
exception that the paternal allele gains methylation in various
brain regions. Therefore, the intragenic Cdh15 DMR is conserved
during adulthood, but in a tissue-specific manner. In humans, the
CDH15 locus does not exhibit allelic DNA methylation in any
tissue (data not shown), suggesting that this tissue-specific meth-
ylation profile might be limited to mice. We cannot rule out the
existence of temporally regulated tissue-specific imprinted DMR in
humans, since our samples were derived from adults, and therefore
any imprinted DMRs specific to the fetal period would be missed.
Our study reveals the power of combining WGBS and Infinium
HumanMethylation450 BeadChip arrays to identify novel im-
printed DMRs. We have previously combined reciprocal genome-
wide UPD samples and the Infinium HumanMethylation27
Figure 4. The methylation profiles of imprinted loci in placenta compared to somatic tissues. The placenta- and leukocyte-derived WGBS and Infinium
array profiles at the (A) PEG10 and (B) H19 loci. Infinium methylation values for normal leukocytes (black dots), with values for the genome-wide pUPD
(blue) and mUPD (red) superimposed on the leukocyte WGBS track. Similarly, Infinium methylation values for normal placenta (black dots) and hydatidiform
mole (blue dots) are overlaid on the placental WGBS track. The error bars associated with the Infinium array probes represent the standard deviation of
multiple biological samples. Bisulfite PCR analysis was used to confirm the tissue-specific methylation profiles. (C ) Complex tissue-specific allelic meth-
ylation and expression patterns at the ZNF331-MIR512 cluster locus on chromosome 19. The ZNF331 sequence traces represent the RT-PCR products from
leukocytes, whereas both the MIR512-1 cluster and MIR371/2 are from placenta. (D) A placental-specific imprinted DMR identified using the placenta-
derived WGBS and Infinium array data sets. The methylation profiles were confirmed using standard bisulfite PCR on heterozygous DNA samples with
allelic RT-PCR performed on placental biopsies. The results confirm that the region of maternal methylation overlapping the AGBL3 promoter dictates
paternal expression of this gene in placenta.
Screening for human imprinted DMRs
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BeadChip arrays to identify imprinted loci (Nakabayashi et al.
2011). All new regions of ubiquitous imprinted methylation
identified in the current screen are associated predominantly with
type II Infinium probes and were not present on previous array
platforms. Of the placental-specific DMRs, only those associated
with DNMT1, AIM1, and MCCC1 have been previously described
(Yuen et al. 2011; Das et al. 2013). Intriguingly, the somatic promoter
of Dnmt1 is differentially methylated between sperm and oocytes
but is lost during preimplantation development (Smallwood et al.
2011; Kobayashi et al. 2012). Two of these placental-specific DMRs
are associated with type I Infinium probes and were previously
discovered using the Infinium HumanMethylation27 BeadChip
arrays with DNA derived from diandric and digynic triploid pla-
cental samples (Yuen et al. 2011).
Our data provide the first direct evidence in humans that the
differential methylation associated with imprinted genes is dy-
namically regulated upon fusion of the gametes at fertilization.
Most maternally methylated DMRs are surrounded by regions of
complete methylation in both gametes, and as in mice, the DMRs
are clearly observed as unmethylated islands in the sperm genome.
These unmethylated intervals are often more extensive in sperm
compared to somatic tissues, suggesting that resizing occurs during
embryonic transition. It was recently reported that nucleosomes
are retained at specific functional regions in sperm chromatin and
are refractory to protamine exchange (Hammoud et al. 2009).
These sperm-derived histones are enriched for H3K4me3, a per-
missive modification that is mutually exclusive with DNA meth-
ylation, implicating these H3K4me3 regions in the maintenance
of the unmethylated state in the male germline.
Imprints are distinguishable from other forms of gametic
methylation as they survive the reprogramming that initiates im-
mediately upon fertilization (Smallwood et al. 2011; Kobayashi
et al. 2013; Proudhon et al. 2012). By comparing the profiles of
sperm, phES, and conventional hES cells along with somatic tis-
sues, we present evidence that most maternally methylated DMRs
are not completely refractory to reprogramming, as highlighted by
the substantial resizing of the paternally derived unmethylated
alleles. These data are consistent with the notion that the cores of
imprinted DMRs are protected from Tet-associated demethylation
by recruiting heterochromatic factors such as ZFP57 and DPPA3
(also known as STELLA or PGC7) (Nakamura et al. 2007; Li et al.
2008). Similar mechanisms could also act to protect the core of the
unmethylated paternal alleles from methylation.
A search for the mouse ZFP57 recognition sequence
(TGCCmetGC) identified numerous binding sites within the ubiq-
uitous imprinted DMRs that may be involved in protecting meth-
ylation during preimplantation reprogramming (Quenneville et al.
2011). It is currently unknown if this hexonucleotide motif is bound
by ZFP57 in human cells, but patients with mutated ZFP57 lack DNA
binding capacity in in vitro EMSA studies (Baglivo et al. 2013).
There are significantly fewer ZFP57 sequence motifs in the
placental-specific DMRs compared to the ubiquitous DMRs that
inherit methylation from the germline (P < 0.05, Student’s t-test),
with 14/17 placental-specific DMRs being unmethylated and not
associated with H3K9me3 in hES cells (Supplemental Fig. S10).
These data further support our hypothesis that a novel imprinting
mechanism occurs in the placenta, which is one of the first ex-
amples of methylation-independent epigenetic inheritance in
mammals. In support of our observations, Park and colleagues
(Park et al. 2004) generated a H19 ICR knock-in at the Afp locus
which was de novo methylated around gastrulation, implying that
H19 ICR is differentially marked in the gametes by a mechanism
other than methylation. However, it is unknown if this mecha-
nism also occurs at the endogenous H19 locus. In our examples of
placental-specific DMRs, the epigenetic mark inherited from the
oocyte is currently unknown, but must be recognized by the de
novo methylation machinery during early trophoblast differenti-
ation, since we observe maternal methylation in term placenta.
Certain histone methylation states are reported to recruit DNMTs
(Dhayalan et al. 2010; Zhang et al. 2010). Since various post-
translational modifications of histone tails have been shown to be
present at imprinted loci, specifically in the placenta independent
of DNA methylation (Umlauf et al. 2004; Monk et al. 2006), we are
led to suggest one inviting hypothesis: A histone modification
confers the ‘‘imprint’’ at these novel placental-specific imprinted
loci. Alternatively, the DNMTs may be recruited to these loci by
a specific, yet to be identified, transcription factor expressed during
early trophoblast differentiation.
In line with other well-characterized imprinted genes in the
placenta, the placental-specific imprinted transcripts may also
exert supply-and-demand forces between the developing fetus and
mother, ultimately influencing fetal adaptation in utero, which if
disrupted may have long-term consequences on health many de-
cades after delivery (Constância et al. 2004). Our observation of
imprinting of the somatic promoter of DNMT1 in placenta may
therefore assist in this process. In addition, numerous studies have
also suggested that children born as a result of assisted re-
productive technologies (ART), including ovarian stimulation, in
vitro fertilization, and intra-cytoplasmic sperm injections, have
a higher risk of diseases with epigenetic etiologies, including im-
printing disorders (Amor and Halliday 2008). In a clinical context,
the placenta-specific imprinted loci may be prone to epigenetic
instability during ART, as the first differentiation step that results
in the trophectoderm occurs when the developing blastocysts are
in culture.
By utilizing genome-wide methylation profiling at base-pair
resolution, we have catalogued regions of parentally inherited
methylation associated with imprinted regions and highlighted all
differences between somatic and placental tissues. Further studies
of these loci will provide insight into the causes of epigenetic ab-
Figure 5. Methylation in gametes, hES cells, and somatic tissues. (A) Heat maps for Infinium probes mapping within all ubiquitous (left) and placental-
specific (right) imprinted DMRs in sperm and phES cells reveal the germline acquisition of methylation. (B) Methylation contour plots from WGBS data sets
for all maternally methylated DMRs reveal that the extent of the intermediately methylated regions associated with imprinted DMRs are extremely
consistent between somatic tissues and significantly larger in sperm. (C ) Methylation profiles at the NNAT DMR determined by WGBS, Infinium array, and
meDIP-seq data sets in leukocytes, sperm, phES cells, and hES cells, along with the H3K4me3 ChIP-seq reads for hES cells and sperm. The gray and black
dots in the second panel represent Infinium probe methylation in hES cell lines derived from six-cell blastomeres (Val10B) and blastocytes (SHEF5),
respectively. The gametic WGBS methylation profile is derived from sperm, with Infinium probe methylation values for sperm and phES cells represented
by blue and red dots. The graphic shows the extent of the differentially methylated regions in somatic tissues and between sperm and phES cells. The error
bars associated with the Infinium array probes represent the standard deviation of the two sperm samples and four independent phES cell lines. The
H3K4me3 ChIP-seq data is from sperm. The methylation profiles were confirmed using standard bisulfite PCR and sequencing.
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errations associated with imprinting disorders and may be relevant
to the epigenetic causes of common diseases.
Methods
Tissue samples and cell lines
Peripheral blood was obtained from healthy volunteers or from the
umbilical cord of newborns for which we obtained matched pla-
cental biopsies. These samples were collected at the Hospital St.
Joan De Deu (Barcelona, Spain) and the National Center for Child
Health and Development (Tokyo, Japan). All placenta-derived
DNA samples were free of maternal DNA contamination based on
microsatellite repeat analysis. The brain samples were obtained
from BrainNet Europe/Barcelona Brain Bank. Ethical approval for
this study was granted by the Institutional Review Boards at the
National Center for Child Health and Development (project 234),
Saga University (21-5), Hamamatsu University School of Medicine
(23-12), Hospital St. Joan De Deu Ethics Committee (35/07), and
Bellvitge Institute for Biomedical Research (PR006/08). Written
informed consent was obtained from all participants.
The hES (SHEF 3, 5, 6 and Val10B) and parthenogenetically
activated oocyte (LLC6P, LLC7P, LLC8P, and LLC9P) cell lines were
used because they were epigenetically stable at imprinted loci
(with the exception of NNAT LOM and GNAS GOM in LLC7P;
LOM of PEG3 in Val10B; GOM of MCTS2P in SHEF3) and grown as
previously described (Harness et al. 2011). Ethical approval for the
study of these cells was granted by the Bellvitge Institute for Bio-
medical Research Ethics Committee (PR096/10) and Comité Ético
de Investigación Clı́nica (CEIC) del Centro de Medicina Regener-
ativa de Barcelona-CMR[B] (28/2012) and complied with the legal
guidelines outlined by the Generalitat de Catalunya El conseller de
Slaut.
Wild-type mouse embryos and placentae were produced by
crossing C57BL/6 (B) with Mus musculus molosinus (JF1) or Mus
musculus castaneous (C) mice. Mouse work was approved by the
Institutional Review Board Committees at the National Center for
Child Health and Development (approval number A2010-002).
Animal husbandry and breeding were conducted according to the
institutional guidelines for the care and the use of laboratory ani-
mals. DNA and RNA extractions and cDNA synthesis were carried
out as previously described (Monk et al. 2006).
Characterization of the genome-wide UPD samples
Genomic DNA was isolated from two previously described
genome-wide paternal UPD cases with BWS features (Romanelli
et al. 2011) and two newly identified individuals, at Saga Uni-
versity, as well as one genome-wide maternal UPD with a SRS
phenotype (Yamazawa et al. 2010). Each of these cases had under-
gone extensive molecular characterization to confirm genome-wide
UPD status and the extent of mosaicism. We used DNA isolated
from lymphocytes, as these samples had minimal contamination
of the biparental cell lines. The genome-wide pUPD samples had
9, 11, 9, and 2% biparental contribution, whereas the genome-
wide SRS sample had 16%. In addition, four hydatidiform moles
were collected by the National Center for Child Health and
Development.
Genome-wide methylation profiling
We analyzed six publicly available methylomes, including those
derived from CD4+ lymphocytes (GSE31263) (Heyn et al. 2012), brain
(GSM913595) (Zeng et al. 2012), the H1 hES cell line (GSM432685,
GSM432686, GSM429321, GSM429322, GSM429323), and sperm
(GSE30340). In addition, we generated three additional tissue
methylomes using WGBS for brain, liver, and placenta. WGBS
libraries were generated as previously described (Heyn et al.
2012).
We also generated methylation data sets using the Illumina
Infinium HumanMethylation450 BeadChip arrays, which simul-
taneously quantifies ;2% of all CpG dinucleotides. Bisulfite con-
version of 600 ng of DNA was performed according to the manu-
facturer’s recommendations for the Illumina Infinium Assay (EZ
DNA methylation kit, Zymo). The bisulfite-converted DNA was
used for hybridization following the Illumina Infinium HD
methylation protocol at genomic facilities of the Cancer Epige-
netics and Biology Program (Barcelona, Spain) or the National
Center for Child Health and Development. Data was generated
for the genome-wide UPDs (43 pUPD, 13 mUPD), two brain, one
liver, one muscle, one pancreas, two sperm, four hydatidiform
moles, four term placentae, four phES cell lines, and the four
hES lines. In addition, we used three leukocyte data sets from
GSE30870.
Data filtering and analysis
For WGBS, the sequence reads were aligned to either strand of
the hg19 reference genome using a custom computational
pipeline (autosomal CpGs with at least five reads: brain sample,
190,314,071 aligned unique reads, 83% coverage; liver sample,
778,733,789 aligned unique reads, 96.6% coverage; placenta
sample, 319,362,653 aligned unique reads, 89.6% coverage).
The methylation level of each cytosine within CpG dinucleo-
tides was estimated as the number of reads reporting a C, divided
by the total number of reads reporting a C or T. For the identi-
fication of intermediately methylated regions associated with
imprinted DMRs, we performed a sliding window approach in
which the methylation of 25 CpGs was averaged after filtering
for repetitive sequences. The location of these sequences was
taken from the UCSC sequence browser. An interval was con-
sidered partially methylated if the average methylation was
0.25 < mean 6 1.5 SD < 0.75.
For the Illumina Infinium HumanMethylation 450 BeadChip
array, before analyzing the data, we excluded possible sources of
technical biases that could influence results. We applied signal
background subtraction, and inter-plate variation was normalized
using default control probes in BeadStudio (version 2011.1_Infinium
HD). We discarded probes with a detection P-value >0.01. We also
excluded probes that lacked signal values in one or more of the
DNA samples analyzed. In addition, we discarded 16,631 probes as
they contained SNPs present in >1% of the population (dbSNP
137). Lastly, prior to screening for novel imprinted DMRs, we ex-
cluded all X chromosome CpG sites. In total, we analyzed 442,772
probes in all DNA samples. All hierarchical clustering and b-value
evaluation was performed using the Cluster Analysis tool of the
BeadStudio software.
In-house R-package scripts were used to evaluate the average
methylation of three contiguous Infinium probes. To identify re-
gions with potential allelic methylation, we screened the re-
ciprocal genome-wide UPDs for three consecutive probes with an
average b-value difference greater than 0.3 (Limma linear model
P < 0.05):
1
3
+
2
n¼0
pUPDsn 
1
3
+
2
n¼0
mUPDn

 > 0:3:
With the condition that the average of three consecutive probes for
the normal leukocytes is between the values for the reciprocal
genome-wide UPDs:
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1
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1
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1
3
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The final condition was that the average of three consecutive
probes for normal leukocytes is within the 0.25–0.75 intermediate
methylation range:
0:25 >
1
3
+
2
n¼0
Leukocytesn > 0:75:
Genotyping and imprinting analysis
Genotypes of potential SNPs identified in the UCSC Genome
Browser (hg19) were obtained by PCR and direct sequencing. Se-
quence traces were interrogated using Sequencher v4.6 (Gene
Codes Corporation) to distinguish heterozygous and homozygous
samples. Heterozygous sample sets were analyzed for either allelic
expression using RT-PCR or bisulfite PCR, incorporating the
polymorphism within the final PCR amplicon so that parental
alleles could be distinguished (for primer sequence, see Supple-
mental Table S3).
Bisulfite PCR
Approximately 1 mg DNA was subjected to sodium bisulfite treat-
ment and purified using the EZ DNA Methylation-Gold kit (Zymo),
and was used for all bisulfite PCR analysis. Approximately 2 mL of
bisulfite-converted DNA was used in each amplification reaction
using Immolase Taq polymerase (Bioline) at 35–45 cycles, and the
resulting PCR product cloned into pGEM-T easy vector (Promega)
for subsequent subcloning and sequencing (for primer sequence,
see Supplemental Table S3). For the confirmation of an imprinted
DMR, we analyzed a minimum of three heterozygous samples and,
where possible, two different tissues.
Chromatin immunoprecipitation (ChIP)
We analyzed publicly available H3K4me3 ChIP-seq and meDIP-seq
data sets, including those derived from lymphocytes (GSM772948,
GSM772836, GSM772916, GSM543025, GSM613913), brain
(GSM806943, GSM806935, GSM806948, GSM669614, GSM669615),
and the H1 hES cell line (GSM409308, GSM469971, GSM605315,
GSM428289, GSM456941, GSM543016). For H3K9me3 in hES cells,
we used GSM450266. In addition, we used the sperm ChIP-seq
data set for H3K4me3 as a direct measure of nucleosome occu-
pancy (GSM392696, GSM392697, GSM392698, GSM392714,
GSM392715, GSM392716) (Hammoud et al. 2009).
The confirmation of allelic H3K4me3 in leukocytes or lym-
phoblastoid cell lines was performed as previously described
(Iglesias-Platas et al. 2013). Briefly, 100 mg of chromatin was used
for an immunoprecipitation reaction with Protein A agarose/
salmon sperm DNA (16-157, Millipore) and a H3K4me3 (07-473,
Millipore). Each ChIP was performed in triplicate alongside
a mock immunoprecipitation with an unrelated IgG antiserum,
and a 1% fraction of the input chromatin was extracted in
parallel. Levels of immunoprecipitated chromatin at each specific
region were determined by qPCR using SYBR Green (Applied Bio-
systems) carried out on the Applied Biosystems 7900 Fast real-time
PCR system (for primer sequence, see Supplemental Table S3). Each
PCR was run in triplicate and protein binding was quantified as
a percentage of total input material.
Data access
The data from this study have been submitted to the NCBI Gene
Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/)
under accession number GSE52578.
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